International Business Machines CORP Form 4 insider transactions
NYSE
IBM Director Michael Miebach deferred fees into 324 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Frederick William McNabb III deferred fees into 324 Promised Fee Shares, increasing his beneficial ownership of derivative securities to 15,223.
NYSE
IBM Director Andrew N. Liveris deferred a portion of his compensation into 346 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Michelle J. Howard deferred fees into 292 Promised Fee Shares, increasing her beneficial ownership to 15,580 shares.
NYSE
IBM Director Alex Gorsky deferred compensation into 381 Promised Fee Shares, increasing his beneficial ownership to 32,805 derivative securities.
NYSE
IBM Director David N. Farr defers fees into 209 equity shares, aligning interests with long-term shareholder value.
NYSE
IBM Director Thomas Buberl defers compensation into 324 Promised Fee Shares, increasing his beneficial ownership to 13,428 derivative securities in a pre-planned transaction.
NYSE
IBM Director Marianne Catherine Brown reported the deferral of fees into 324 Promised Fee Shares, valued at $282.16 per share, under a pre-arranged plan, with distribution deferred until retirement.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, reported the vesting of restricted stock units, a tax-related disposition, a stock gift, and a new RSU grant.
NYSE
Form 4: IBM Senior Vice President Anne Robinson Reports Routine Stock Transactions Following RSU Vesting
IBM Senior Vice President Anne Robinson reported the acquisition of common stock through restricted stock unit vesting and subsequent disposition of shares for tax withholding purposes.
NYSE
IBM Director Frederick H. Waddell has elected to defer 331 Promised Fee Shares, valued at $294.78 per share, into the company's common stock under a deferred compensation plan, increasing his total beneficial ownership of derivative securities to 22,074.
NYSE
IBM Director Peter R. Voser has deferred 340 Promised Fee Shares into the company's equity plan, increasing his beneficial ownership to 30,365 derivative securities.
NYSE
IBM Director Martha E. Pollack has deferred 196 Promised Fee Shares, valued at $294.78 per share, into the company's deferred compensation plan, increasing her beneficial ownership of derivative securities to 16,224.
NYSE
IBM Director Michael Miebach has increased his beneficial ownership of IBM common stock by deferring compensation into 310 Promised Fee Shares.
NYSE
An IBM director has deferred a portion of their compensation into 310 Promised Fee Shares, aligning their interests with shareholders through the company's deferred compensation plan.
NYSE
IBM Director Andrew Liveris has elected to defer a portion of his compensation into 331 Promised Fee Shares under the company's deferred compensation plan, increasing his beneficial ownership of derivative securities to 42,008.
NYSE
IBM Director Michelle J. Howard has deferred compensation into 279 Promised Fee Shares under the company's Board of Directors Deferred Compensation and Equity Award Plan, increasing her beneficial ownership to 15,189 shares.
NYSE
IBM Director Alex Gorsky acquired 365 Promised Fee Shares through a deferred compensation plan, increasing his total beneficial ownership to 32,213 derivative securities.
NYSE
IBM Director Marianne Catherine Brown deferred a portion of her compensation into 310 Promised Fee Shares, valued at $294.78 per share, under the company's deferred compensation plan.
NYSE
IBM Director David N. Farr acquired 196 Promised Fee Shares through a compensation deferral plan, increasing his beneficial ownership to 21,921 shares, with distribution deferred until retirement.
NYSE
An IBM director has elected to defer a portion of their compensation into 310 'Promised Fee Shares' under the company's deferred compensation plan, aligning their interests with shareholders.
NYSE
IBM Director Alfred W. Zollar has deferred fees into 310 Promised Fee Shares under the company's Deferred Compensation and Equity Award Plan, with distribution deferred until retirement.
NYSE
IBM Senior Vice President Robert David Thomas reported the vesting of the final tranche of his restricted stock units and the subsequent sale of shares for tax purposes on June 8, 2025.
NYSE
Form 4: IBM Senior VP Nickle Jaclyn Lamoreaux Reports Routine Stock Transactions Following RSU Vesting
IBM Senior Vice President Nickle Jaclyn Lamoreaux reported the vesting of restricted stock units and subsequent tax-related share disposition, a routine compensation event.
NYSE
IBM's Chairman, President, and CEO, Arvind Krishna, increased his direct beneficial ownership of IBM common stock by 4,308 shares following the vesting of restricted stock units and a concurrent tax-related disposition.
NYSE
IBM's Senior Vice President and CFO, James J. Kavanaugh, reported changes in his direct common stock holdings due to the vesting of restricted stock units and subsequent tax-related share disposition.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, reported the vesting of 500 restricted stock units and the subsequent sale of 262 shares to cover tax obligations on June 8, 2025.
NYSE
Form 4: IBM Director Alex Gorsky Reports Acquisition of Common Stock Through Deferred Compensation Plan
Director Alex Gorsky reports acquiring 433 shares of IBM common stock on March 31, 2025, through a deferral of fees under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
NYSE
Form 4: IBM Director Marianne Brown Reports Acquisition of Common Stock Through Deferred Compensation Plan
Director Marianne Brown reports acquisition of 367 shares of IBM common stock through a deferred compensation plan.
NYSE
Form 4: IBM Director Thomas Buberl Reports Acquisition of Common Stock Through Deferred Compensation Plan
Director Thomas Buberl reports acquisition of 367 shares of IBM common stock through the IBM Board of Directors Deferred Compensation and Equity Award Plan.